Skip to content
Noroxi
NVD / CVE Program· CNA EEF

CVE-2026-28806: Improper authorization in device bulk actions and device update API allows cross-organization device control

CriticalCVSS 9.4 · v4.0—No exploit Fix available

Noroxi assessment

Priority: Monitor (action score 37/100)

  • The sources we track (CISA KEV, Exploit-DB, Metasploit, Nuclei, GitHub) show no public exploit code or exploitation in the wild.
  • Probability of exploitation in the next 30 days: 0.48% (FIRST EPSS).
  • Anyone who can reach it over the internet can trigger it. A low-privileged account is enough. No user action is required. No special conditions are required; it is repeatable.
  • Fixed version: nerves-hub nerves_hub_web 1f69c9d595684a4650c3ac702f3dc7c5bcd7526c, 2.4.0.

Low priority for now. Upgrade to nerves-hub nerves_hub_web 1f69c9d595684a4650c3ac702f3dc7c5bcd7526c, 2.4.0 or later.

Generated automatically from the record's data: CVSS (NVD and CNA), CISA KEV and SSVC, FIRST EPSS, exploit sources, fixed versions. How we calculate it

Primary sources: NVD · CVE.org · FIRST EPSS

Improper Authorization vulnerability in nerves-hub nerves_hub_web allows cross-organization device control via device bulk actions and device update API. Missing authorization checks in the device bulk actions and device update API endpoints allow authenticated users to target devices belonging to other organizations and perform actions outside of their privilege level. An attacker can select devices outside of their organization by manipulating device identifiers and perform management actions on them, such as moving them to products they control. This may allow attackers to interfere with firmware updates, access device functionality exposed by the platform, or disrupt device connectivity. In environments where additional features such as remote console access are enabled, this could lead to full compromise of affected devices. This issue affects nerves_hub: from 1.0.0 before 2.4.0.

Published
Mar 10, 2026
Updated
Nov 11, 2026
EPSS
0.4% · 42th percentile

Report tools

JSON

Action score

37

Monitor

Low priority for now.

CVSS
37 / 40 · 9.4 / 10
CISA KEV
0 / 30 · Not listed
EPSS
0 / 30 · 0.4%

CISA SSVC decision

Exploitation
none
Automatable
no
Technical impact
total

Vulnrichment: CISA's decision-tree inputs.

CNA vs NVD score

NVD
—
CNA · EEF
9.4
NVD has not scored this yet; the score shown is the CNA’s.

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H

The score given by the assigning authority versus NVD’s independent score. A gap means the severity is contested.

Get told when this record changes

  • Not in KEV: no record of exploitation in the wild
  • No public exploit code on record
  • A fix has been released

If any of these changes, we'll tell you in the daily email digest.

Follow CVE-2026-28806

When you'll hear from us

  • when it enters CISA KEV
  • when exploit code appears or is weaponized
  • when the record is updated (including a fixed version)
  • when EPSS rises 20 points in a week

One daily email digest (06:00 UTC); connect a webhook for KEV listings and weaponized exploits every 10 minutes on paid plans, on the hour on the free plan.

Your free account also gets you

  • CVE alerts: add the products and versions you run, get the new CVEs that affect them
  • Uptime monitoring: 1 site, instant email when it goes down
  • Add your domain: subdomains and takeover risk scanned every week (1 domain)
  • 10 scans an hour on the security tools, at most 30 a day (3 a day without an account), an API key and MCP
  • All your scans in one panel: findings, what changed in the last scan, a report per domain or per client (PDF, share link)
All free tools

Sign up with email · Have an account? Sign in

Free account, no card. Unfollow any time.

Don't want an account? Get "Exploited this week" by email every MondayDon't want an account? RSS feed for nerves-hub records
Is your version affected? Check it

Noroxi analysis

What does it mean in your environment?

The assessment above is generated automatically from the record's data; it doesn't know your environment. Our team verifies on your systems whether this vulnerability is actually exploitable and which mitigation is enough.

We use this product, ask for help

Affected systems

Is your version affected?

Pick the product and type the version you run. It's compared with this record's version ranges in your browser; the version isn't sent anywhere.

VendorProduct
nerves-hubnerveshub

Versions reported by the vendor

Affected version ranges reported by the assigning authority (EEF). Independent of NVD's CPE analysis and usually ahead of it.

  • nerves-hub nerves_hub_web

    • 1.0.0 and later · before 2.4.0affected · semver
    • 1.0.0 and later · before 2.4.0affected · other
    • adaeefdb7a835525482588f43332ef988cc448c7 and lateraffected · git
    • 79743ef08f7f801617b653fd09f37c01ed9b4be0 and later · before 1f69c9d595684a4650c3ac702f3dc7c5bcd7526caffected · git

Affected versions

NVD version ranges (for catalog products). Add the product to your stack with a version and matching uses these.

  • nerves-hub nerveshub1.0.0 and later · before 2.4.0

Same product

nerves-hub: all records

Other highest-scoring records for the same primary product.

  • CVE-2025-64097NervesHub has Insufficient Token Entropy that Allows Authentication Bypass via Brute Force
    38Monitor

Remediation

Which version to upgrade to

Fix versions compiled from the vendor, package registries and Microsoft. Verify the vendor's note before upgrading.

Product / packageFixed versionSource
nerves-hub nerves_hub_web1f69c9d595684a4650c3ac702f3dc7c5bcd7526cVendor (CNA)
nerves-hub nerves_hub_web2.4.0Vendor (CNA)

Exploit status

No known public exploit

No public exploit has been observed yet. That doesn't mean you're safe, only that the bar is a little higher.

Research context

For pentesters and researchers: attack profile, score disagreement, timeline, patch commits, credits, variant and chain candidates, bug bounty scope. All derived from existing data; no exploit code.

Timeline

From publication to today: proof of concept, Metasploit module, CISA KEV and fix record. Dates are as reported by the sources.

No dated events beyond publication.

Patch and commit links

Commit, PR and diff links among the references. A starting point for patch-diffing and variant hunting; fixes, not exploits.

Credits

All researchers

Finders, reporters and analysts named in the CNA record. Click a name for that researcher’s other records.

Not on record for this CVE: EPSS history · variant or chain candidate · public bounty program.

Technical details

Attack conditions

  • Anyone who can reach it over the internet can trigger it.
  • A low-privileged account is enough.
  • No user action is required.
  • No special conditions are required; it is repeatable.

If successful

Confidentiality
Integrity
Availability
Attack vector
Network
Attack complexity
Low
Privileges required
Low
User interaction
None
Scope
X

Weakness class (CWE)

CWE-285 · Improper Authorization

CVSS vector

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

nvd-secondary

Attack context

MITRE CAPEC attack patterns and ATT&CK techniques for this weakness class (CWE). A starting point for detection rules and threat hunting.

References

Show all references (5 more)

Vendor advisories and official records. Exploit/PoC links are deliberately left out.

All records